ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

American Urological Association Announces 2025 Gallagher Health Policy Scholar

BALTIMORE, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) is pleased to announce Michael Davis, MD, MBA, MHA, FACS, has been named the 2025 AUA Gallagher Health Policy Scholar.

A highly competitive award, the Gallagher Health Policy Scholar Program is a rigorous year-long training initiative aiming to equip urologists for leadership roles in health policy. Established in 2007, the program pays tribute to G. James Gallagher, former Executive Director of the AUA.

The program sponsors the current scholar each year to participate in national conferences and meetings and provides mentorship from senior AUA physicians. Additionally, scholars engage in a week-long health policy seminar for surgeons supported by the American College of Surgeons. The program organizes educational activities yearly to enhance scholars' comprehension of contemporary health policy issues affecting urology care.

"Dr. Davis embodies the excellence and leadership the Gallagher Scholar Award recognizes. With over three decades of transformative contributions to the field of urology, his dedication to clinical innovation, education and service is unparalleled,” said AUA Public Policy Council Chair Dr. Mark Edney. "His extensive expertise, leadership roles and commitment to advancing health care make him a truly deserving recipient of this prestigious honor.” 

Dr. Davis is a distinguished urologist, educator and health care leader with over 30 years of experience. He serves as chief of the Division of Urology, vice chair of Clinical Affairs and surgical director of the Renal Transplant Program at the University of New Mexico. A certified abdominal transplant surgeon, Dr. Davis has performed over 600 kidney transplants and has been repeatedly recognized as a “Top Doc” in urology.

Dr. Davis holds advanced business and health care administration degrees and is a fellow of the American College of Surgeons. He is deeply committed to education, serving as a mentor to students, residents and colleagues and has contributed extensively to professional organizations, including the AUA, where he has been a member since 2003. In the last 20+ years, he has been a state representative for the South Central Section, an AUAPAC champion for the South Central Section and has presented posters and abstracts at numerous annual meetings.

“I am incredibly excited and deeply honored to be nominated as the next Gallagher Health Policy Scholar,” said Dr. Davis. “I look forward to this prestigious opportunity, which will give me a broader understanding of the health care policy that affects our ability to care for patients and the skills to advocate for urology as a specialty.”

Read more information on the Gallagher Scholarship on our website at auanet.org/gallagher

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 25,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.

Attachment


Corey Del Bianco
American Urological Association
2678854989
cdelbianco@auanet.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.